WallStreetZenWallStreetZen

NASDAQ: MRKR
Marker Therapeutics Inc Stock

$2.70+0.06 (+2.27%)
Updated Feb 3, 2023
MRKR Price
$2.70
Fair Value Price
$4.86
Market Cap
$22.57M
52 Week Low
$2.20
52 Week High
$6.60
P/E
-0.63x
P/B
1x
P/S
4.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.95M
Earnings
-$35.84M
Gross Margin
100%
Operating Margin
-515.94%
Profit Margin
-515.9%
Debt to Equity
0.82
Operating Cash Flow
-$26M
Beta
1.11
Next Earnings
Mar 15, 2023
Ex-Dividend
N/A
Next Dividend
N/A

MRKR Overview

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MRKR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MRKR ($2.70) is undervalued by 44.47% relative to our estimate of its Fair Value price of $4.86 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MRKR ($2.70) is significantly undervalued by 44.47% relative to our estimate of its Fair Value price of $4.86 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MRKR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MRKR due diligence checks available for Premium users.

Be the first to know about important MRKR news, forecast changes, insider trades & much more!

MRKR News

Valuation

MRKR fair value

Fair Value of MRKR stock based on Discounted Cash Flow (DCF)
Price
$2.70
Fair Value
$4.86
Undervalued by
44.47%
MRKR ($2.70) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MRKR ($2.70) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MRKR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MRKR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.63x
Industry
10.7x
Market
15.09x

MRKR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1x
Industry
5.11x
MRKR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MRKR's financial health

Profit margin

Revenue
$3.9M
Net Income
-$6.9M
Profit Margin
-175.2%
MRKR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MRKR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$41.1M
Liabilities
$18.5M
Debt to equity
0.82
MRKR's short-term assets ($22.42M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRKR's short-term assets ($22.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRKR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MRKR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.6M
Investing
-$99.4k
Financing
$0.0
MRKR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MRKR vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
MRKR$22.57M+2.27%-0.63x1.00x
SGTX$22.75M-2.64%-0.41x0.51x
ABVC$22.94M-0.99%-1.03x3.88x
HGEN$22.98M+4.89%-0.13x-0.44x
ATHX$21.99M+6.25%-0.22x-1.32x

Marker Therapeutics Stock FAQ

What is Marker Therapeutics's quote symbol?

NASDAQ: MRKR) Marker Therapeutics trades on the NASDAQ under the ticker symbol MRKR. Marker Therapeutics stock quotes can also be displayed as NASDAQ: MRKR.

If you're new to stock investing, here's how to buy Marker Therapeutics stock.

What is the 52 week high and low for Marker Therapeutics (NASDAQ: MRKR)?

(NASDAQ: MRKR) Marker Therapeutics's 52-week high was $6.60, and its 52-week low was $2.20. It is currently -59.09% from its 52-week high and 22.73% from its 52-week low.

How much is Marker Therapeutics stock worth today?

(NASDAQ: MRKR) Marker Therapeutics currently has 8,359,919 outstanding shares. With Marker Therapeutics stock trading at $2.70 per share, the total value of Marker Therapeutics stock (market capitalization) is $22.57M.

Marker Therapeutics stock was originally listed at a price of $54.70 in Nov 8, 2016. If you had invested in Marker Therapeutics stock at $54.70, your return over the last 6 years would have been -95.06%, for an annualized return of -39.43% (not including any dividends or dividend reinvestments).

How much is Marker Therapeutics's stock price per share?

(NASDAQ: MRKR) Marker Therapeutics stock price per share is $2.70 today (as of Feb 3, 2023).

What is Marker Therapeutics's Market Cap?

(NASDAQ: MRKR) Marker Therapeutics's market cap is $22.57M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Marker Therapeutics's market cap is calculated by multiplying MRKR's current stock price of $2.70 by MRKR's total outstanding shares of 8,359,919.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.